47 results about "Adenoid" patented technology

A method is disclosed for treating benign conditions, such as enlarged tonsils and/or adenoids located in a patient's throat or nasopharynx, or soft tissue lesions located in a patient's oropharynx or larynx. According to the method, a space containing the patient's nasopharynx, oropharynx or pharynx and larynx is isolated from the patient's trachea and lungs using an inflatable cuff tracheostomy tube or nasotracheal tube inserted in the patient's trachea. The cuff is inflated to occlude the trachea. The patient is placed in a supine position, whereupon at least a portion of the space containing the nasopharynx and/or oropharynx and larynx is filled with saline. An endoscope is then inserted into the space to view the operative site in which the tonsils or tissue lesion are to be treated. An electrosurgical instrument having an active tissue treatment electrode and a return electrode connected to an electrosurgical generator is then inserted into the space, either along side the endoscope or through the endoscope's working channel. The generator is then operated to apply a radio frequency voltage between the active and return electrodes of the electrosurgical instrument, whereby a conduction path is formed between the active and return electrodes, at least partially through the saline, whereupon the active electrode is manipulated to debulk or otherwise treat the soft tissue lesion or enlarged tonsils and/or adenoids.

The invention provides a polymeric film-forming medical sealant. The medical sealant is useful for application to the tonsils and adenoids, wherein the sealant performs at least one of the following functions, a) inhibit the colonization of bacteria, b) inhibit the binding of bacteria to tissue, c) reduction of tissue morbidity, d) hemostasis, e) coating and protection of tissue during healing. e) promotion of healing, and f) reduction of pain.

A bipolar electrosurgical instrument is disclosed for use in excising tissues. The disclosed bipolar electrosurgical instrument includes a pair of jaws or legs having shearing surfaces, one of which is electrically nonconductive. The disclosed bipolar surgical instrument also includes conductive surfaces on the legs which allow energy flux to flow through tissue on a plane other than that defined by the relative shearing surfaces.

The invention relates to a traditional Chinese medicine composition for treating rhinitis. The traditional Chinese medicine composition is mainly prepared from the following crude drugs: cantharides, rhizoma typhonii, pinellia ternate, bulb of thunberg fritillary, scolopendra, asarum, centipeda minima, sangusis draconis, borneol and musk in a processing manner according to certain parts by weight. The traditional Chinese medicine composition has a good curative effect on treatment of acute rhinitis, chronic rhinitis, adenoidal hypertrophy, nasal polyp, anaphylactic rhinitis and nasosinusitis, and is quick to take effect, short in curative effect, small in side effect, and fewer in used crude drug variety, the recovery rate can be up to 86%, the effective rate can be up to over 97.8%, and the cost is saved. The traditional Chinese medicine composition can be prepared into external paste, such as patches, water aqua, spray or an ointment and the like, and is more convenient to use and carry, and the availability and the curative effect of the composition are further improved.

A surgical instrument includes a housing having a movable handle operably coupled to the housing and movable relative thereto between an initial position and a compressed position. A trigger is operably coupled to the housing within a slot defined therein and movable relative to the housing and the movable handle between an un-actuated position and an actuated position. A flange is disposed on the trigger and configured to extend distally therefrom. The flange is dimensioned to cover the slot when the trigger is moved between the un-actuated and actuated positions to avoid creating a potential pinch point between the trigger and the slot.

The invention relates to a pharmaceutical composition for treating pediatric adenoidal hypertrophy. The pharmaceutical composition comprises the following components in parts by weight: small centipeda herb, fructus gleditsiae, licorice root, orange peel, perilla, honeysuckle, sesame oil, cocklebur fruit, ligusticum wallichii, coptis root, chrysanthemum and peppermint. The pharmaceutical composition is prepared by crushing, stirring and decocting the components, and can be used for treating pediatric adenoidal hypertrophy which is treated without any special medicine except by surgical excision, even if a medicine is administered, the medicine is used for treating rhinitis or tonsils. The pharmaceutical composition provided by the invention is specially developed for adenoids, has a directeffect by dripping from nasal cavity and fills a gap in this field.

The invention discloses an intelligent child sleep monitoring system with an adenoidal hypertrophy probability judgment function. The intelligent child sleep monitoring system comprises a dot matrix infrared camera, a microphone array, a near-infrared LED light source, a sleeping posture and mouth-nose respiration analysis module, a body temperature analysis module, a respiration acoustics analysis module, a blood oxygen analysis module and an adenoidal hypertrophy probability comprehensive judgment module. The intelligent child sleep monitoring system with the adenoidal hypertrophy probability judgment function is different from an existing sleep monitoring product, home sleep monitoring can be conducted on children to judge the adenoidal hypertrophy probability of the children, and objective references are provided for parents and doctors, so that the children with operation indications can be treated in time. According to the present invention, multi-parameter monitoring is carriedout in a non-contact mode, so that the defect that comfort is affected due to the fact that an existing monitoring device needs to be worn can be overcome, and the comprehensiveness and accuracy of amonitoring result can be improved by integrating multiple parameters for analysis.

The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (ADEC) from inflamed adenoid tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode ADEC, expression vectors for the production of purified ADEC, antibodies capable of binding specifically to ADEC, hybridization probes or oligonucleotides for the detection of ADEC-encoding nucleotide sequences, genetically engineered host cells for the expression of ADEC, diagnostic tests for inflammation or disease based on ADEC-encoding nucleic acid molecules or antibodies capable of binding specifically to ADEC.

The invention provides a kind of polymorthy adenoma animal model. Roll FLAG1 expression box from out source in the animal's gene group. The box contains promoter, FLAG1 code list relating to the operation of promoter. The rotuled gene mice get spontaneous salivary gland tumor, which accord with main pathology character of men's multiformity tumor. The invention also provides the preparation of the model and the model's use.

The invention discloses a traditional Chinese medicine component for treating adenoidal tonsil hypertrophy of children and a preparation method thereof. The traditional Chinese medicine component is prepared from the following medicinal materials of, in parts by weight, 4.5-6.3 g of radix rehmanniae recen, 8.2-12.5 g of Chinese yam active peptide dry powder, 6.2-7.1 g of dendrobe, 7.4-9.2 g of poria cocos, 8.4-9.1 g of thunberg fritillary bulb, 5.2-6.3 g of radix scrophulariae, 1.2-3.3 g of endothelium corneum gigeriae galli, 3.4-5.2 g of platycodon grandiflorum, 8.7-9.3 g of wild jujuba seeds, 8.4-9.1 g of fritillaria cirrhosa, 4.2-6.6 g of forsythia suspensa, 5.2- 6.9 g of bupleurum chinense and 2.2-5.6 g of lance asiabell root. The traditional Chinese medicine component has the beneficial effects that various traditional Chinese medicinal materials are mixed and decocted according to a certain weight ratio and are mixed to prepare an oral liquid, after the oral liquid is taken, thehypertrophy phenomenon of adenoid and tonsil of a patient is gradually relieved, meanwhile, the effects of nourishing yin, tonifying a lung, tonifying a kidney and replenishing essence can be achieved, and meanwhile, compared with traditional western medicines, the side effect is low, in addition, the risk is small, meanwhile, a utilization rate of the medicine is relatively high, the quick effectis achieved, and the effect is remarkable.

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating childhood adenoid hypertrophy. The medicine is prepared from the following components: codonopsis pilosula, rhizoma atractylodis macrocephalae, poria cocos, fructus arctii, radix sophorae tonkinensis, bombyx batryticatus, dioscorea bulbifera, seaweed, loquat leaves, flos farfarae and honey. The traditional Chinese medicine composition is reasonable in components and easy to prepare, has significant curative effects of invigorating the spleen to benefit the lung, reducing phlegm, resolving masses, clearing damp, promoting diuresis and clearing away heat and toxic materials, and is an effective medicine for treating childhood adenoid hypertrophy, particularly adenoidal hypertrophy due to childhood lung and spleen deficiency.

The invention belongs to the technical field of gene therapy and diagnosis, in particular relates to the application of a tumor antigen gene XAGE-1 and expression products thereof in tumor therapy and diagnosis. The vital function of XAGE-1 gene in the growth and the transfer of tumors is found for the first time herein, and XAGE-1 gene is an important symbol of tumors. According to the research, XAGE-1 can promote proliferation, transfer and invasion capabilities of cells of adenoid cystocarcinoma of salivary gland and various tumor cells. The gene and the expression products thereof can be used as drug targets to develop various tumor treatment drugs, in particular the drugs for resisting the growth and transfer of tumors. XAGE-1 and the expression products thereof can be used as the symbols of tumors for tumor diagnosis and analysis of illness, and for developing various diagnostic reagent kits and methods, thus significantly improving the diagnosis level of tumors, in particular incipient tumors. The specificity regulatory sequence of XAGE-1 can be applied in tumor therapy and so on according to the transcriptional regulatory mechanism of XAGE-1.

The invention discloses a method for treating adenoid hypertrophy and a preparation method of a special medicine bead ear point stick. The adenoid hypertrophy is also known as pharyngeal tonsillar hypertrophy, and mainly caused by infection or inflammatory lesions; in the past, western medicine operative treatment and adenoidectomy are often used in clinic of child patients, and the residual rateof adenoids is up to 94.9% in the method. The special medicine bead ear point stick is prepared from the components of10-15 g of trollflower, 10-15 g of kadsura root-bark, 5-10 g of rhizome pleionis,5-10 g of spica prunellae, 5-10 g of radix angelicae, 5-10 g of rhizome chuanxiong, 5-8g of pangolin scales, 3-5 g of flos magnolia, 3-5 g of liquoric root and 1-3 g of fructus xanthii. The method andthe preparation method are used for the treatment of adenoid hypertrophy and the preparation of the special medicine bead ear point stick.

A surgical instrument includes a housing having a barrel with distal and proximal end portions. The barrel includes a handle depending from a lower end thereof and a concave portion defined within and extending along an upper surface thereof from the proximal end portion of the barrel to the distal end portion of the barrel. A shaft extends from the distal end portion of the housing and supports an end effector assembly at a distal end thereof configured to treat tissue. The concave portion is configured to enhance visibility of the end effector assembly during tissue treatment.

A levamisole in the form of spray, aerosol, powder spray and nasal drops for treating chronic nasosinusitis and adenoids is disclosed.